Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

4726 Mycenax

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Pei-Jiun Chen

03-6670880

7F., No. 66, Shengyi 2nd RdZhubei City, Hsinchu County, Taiwan

2013/12/25

Industry

Main Business

Biotechnology and Medical Care

Mycenax uses its process development technology and cGMP manufacturing capability in its biological products development and contract development services. Two products (TuNEX, Tumor Necrosis Factor Receptor-Fc and GranNEX, Granulocyte Colony Stimulating Factor) pursue Taiwan IND application in 2006 and start clinical trials in 2007. Other products, through cooperation with collaborators, in the pipeline includes Erithropoitin and anti-her2 human antibody products. Mycenax will expand its successful experiences to new protein drugs development. Mycenax specializes in strategic planning and execution, process development and manufacturing to accelerate the drug development process and minimize expenses.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/04/26 )
4860.803	46.70	42.70	43.85	-2.15	3041		4,223	21
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/04/26)	TPEx measures adopted (2024/04/26)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	Y	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile